In this case, the drug is 30 years old. I’d say any cost to bring to market is well paid now, and even if it isn’t, this is why the public should fund the research via taxes, not locking profits up via corporate entities.
The product is long off patent. The only thing stopping someone from selling it cheaper in the US is the government itself and limited economic returns.